drugset / Trial / NCT00979901

Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)

NCT00979901

Phase 3 Completed 1577 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the ability of montelukast to improve the signs and symptoms of seasonal allergic rhinitis compared with loratadine and placebo.

Timeline

Start
2000-03
Primary completion
2000-05
Completion
2000-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Loratadine Small molecule 10 mg Oral
Subject Montelukast Other / unclassified 10 mg Oral